Listed

Dexcom Inc

DXCMNasdaqCIK 1093557HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.31bnRevenue, Q2 FY2026, three months to 2026-06-30$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 30, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.31bnRevenue, Q2 FY2026, three months to 2026-06-30$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure+13.1% on a year earlier
  • Gross margin63.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $830.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure+3.9 pts on a year earlier
  • Operating margin24.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $318.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure+6.0 pts on a year earlier
  • Net margin19.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $249.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure+3.5 pts on a year earlier
  • Diluted EPS$0.64Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure+42.2% on a year earlier
  • Free cash flow$184.5mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $269.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Capital expenditure: $84.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure−11.7% on a year earlier

Last eight quarters

Full statements
Revenue$1.31bnGross margin 63.4%
Diluted EPS$0.64, Q2 FY2026
Free cash flow$184.5m, Q2 FY2026
Dexcom Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m994Revenue, Q3 FY2024, three months to 2024-09-30$994.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure1,114Revenue, Q4 FY2024, three months to 2024-12-31$1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure1,036Revenue, Q1 FY2025, three months to 2025-03-31$1.04bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure1,157Revenue, Q2 FY2025, three months to 2025-06-30$1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure1,209Revenue, Q3 FY2025, three months to 2025-09-30$1.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure1,260Revenue, Q4 FY2025, three months to 2025-12-31$1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure1,192Revenue, Q1 FY2026, three months to 2026-03-31$1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure1,308Revenue, Q2 FY2026, three months to 2026-06-30$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Gross margin%59.7%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $593.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Revenue: $994.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure58.9%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $655.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Revenue: $1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure56.9%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $589.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Revenue: $1.04bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure59.5%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $688.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure60.5%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $731.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Revenue: $1.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure62.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $792.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Revenue: $1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure62.9%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $750.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Revenue: $1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure63.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $830.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Operating margin%15.3%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $152.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Revenue: $994.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure17.0%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $188.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Revenue: $1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure12.9%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $133.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Revenue: $1.04bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure18.4%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $212.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure20.1%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $242.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Revenue: $1.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure25.6%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $323.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Revenue: $1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure21.4%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $255.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Revenue: $1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure24.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $318.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Net margin%13.5%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $134.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Revenue: $994.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure13.6%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $151.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Revenue: $1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure10.2%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $105.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Revenue: $1.04bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure15.5%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $179.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure23.5%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $283.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Revenue: $1.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure21.2%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $267.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Revenue: $1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure16.7%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $199.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Revenue: $1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure19.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $249.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Diluted EPS$ per share0.34Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figurenot reported (Diluted EPS not reported)0.27Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure0.45Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure0.70Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figurenot reported (Diluted EPS not reported)0.51Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure0.64Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Free cash flow$m88.3Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $199.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Capital expenditure: $111.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure177Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $301.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Capital expenditure: $124.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure96.8Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $183.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Capital expenditure: $87.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure209Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $303.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Capital expenditure: $94.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure579Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $659.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Capital expenditure: $80.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure192Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $294.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Capital expenditure: $101.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure449Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $525.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Capital expenditure: $76.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure185Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $269.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Capital expenditure: $84.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$4.66bnGross margin 60.1%
Diluted EPS$2.09, FY2025
Free cash flow$1.08bn, FY2025
Dexcom Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m2,449Revenue, FY2021, twelve months to 2021-12-31$2.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-08, accession 0001093557-24-000021.Report this figure2,910Revenue, FY2022, twelve months to 2022-12-31$2.91bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure3,622Revenue, FY2023, twelve months to 2023-12-31$3.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure4,033Revenue, FY2024, twelve months to 2024-12-31$4.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure4,662Revenue, FY2025, twelve months to 2025-12-31$4.66bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure
Gross margin%68.6%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $1.68bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-08, accession 0001093557-24-000021.Revenue: $2.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-08, accession 0001093557-24-000021.Report this figure64.7%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $1.88bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-18, accession 0001093557-25-000036.Revenue: $2.91bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure63.2%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $2.29bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $3.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure60.5%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $2.44bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $4.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure60.1%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $2.80bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $4.66bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure
Operating margin%10.9%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $265.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-08, accession 0001093557-24-000021.Revenue: $2.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-08, accession 0001093557-24-000021.Report this figure13.4%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $391.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-18, accession 0001093557-25-000036.Revenue: $2.91bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure16.5%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $597.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $3.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure14.9%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $600.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $4.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure19.6%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $911.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $4.66bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure
Net margin%8.9%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $216.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-08, accession 0001093557-24-000021.Revenue: $2.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-08, accession 0001093557-24-000021.Report this figure11.7%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $341.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-18, accession 0001093557-25-000036.Revenue: $2.91bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure14.9%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $541.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $3.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure14.3%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $576.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $4.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure17.9%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $836.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027.Revenue: $4.66bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure
Diluted EPS$ per share0.53Diluted EPS, FY2021, twelve months to 2021-12-31$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-08, accession 0001093557-24-000021.Report this figure0.82Diluted EPS, FY2022, twelve months to 2022-12-31$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure1.30Diluted EPS, FY2023, twelve months to 2023-12-31$1.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure1.42Diluted EPS, FY2024, twelve months to 2024-12-31$1.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure2.09Diluted EPS, FY2025, twelve months to 2025-12-31$2.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure
Free cash flow$m53.3Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $442.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-08, accession 0001093557-24-000021.Capital expenditure: $389.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-08, accession 0001093557-24-000021.Report this figure305Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $669.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-18, accession 0001093557-25-000036.Capital expenditure: $364.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure512Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $748.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027.Capital expenditure: $236.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure631Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $989.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027.Capital expenditure: $358.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure1,077Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $1.44bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027.Capital expenditure: $363.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $0Sales $201.7k
Dexcom Inc, open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-27Stern SadieEVP Chief People & Culture Off, Officer Sale2,565$78.62$201.7kForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Dexcom Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$2.58bn38,244,137Reduced−720,234
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$1.70bn25,209,752Added+188,791
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$1.32bn19,656,540Added+436,587
STATE STREET CORP2026-06-30$1.24bn18,380,806Added+445,959
Invesco Ltd.2026-06-30$1.03bn15,288,133Added+9,693,273
BAILLIE GIFFORD & CO2026-06-30$996.9m14,801,590Reduced−797,935
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$834.2m12,426,515Added+79,877
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2026-06-30$758.5m11,261,876Added+1,515,702
ALLIANCEBERNSTEIN L.P.2026-06-30$734.3m11,693,409Reduced−1,230,235
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$574.3m8,527,471Reduced−798,769

Recent filings

All 2,232 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Dexcom Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2916:03 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001093557-26-000193
2026-09-1416:33 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001093557-26-000175
2026-09-1016:16 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001093557-26-000167
2026-07-3017:21 ET10-QQuarterly reportPeriod 2026-06-300001093557-26-000143
2026-07-3016:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001093557-26-000142
2026-05-2817:15 ET8-K5.07 Shareholder vote results0001093557-26-000105
2026-05-1519:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events0001093557-26-000085
2026-04-3017:20 ET10-QQuarterly reportPeriod 2026-03-310001093557-26-000073
2026-04-3016:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001093557-26-000072
2026-04-1516:11 ETDEF 14AProxy statementPeriod 2026-05-270001093557-26-000061

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 12, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
1093557
Tickers
DXCM
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:23 ET. Listed shows no prices and gives no investment advice.